Longwood Fund II, L.P.

Longwood Fund II, L.P. is 10% Owner at Flex Pharma, Inc. (FLKS). They have made 2 open-market trades across 1 company since 2015, most recently 2018-10-16.

CIK 0001543245

Get an email the next time Longwood Fund II, L.P. files.Follow for free

1 open-market purchase totalling $5.0M since 2015, against 1 sale. Too few scored purchases to measure a record yet.

Also files as

Controlled by Christoph H. Westphal

Christoph H. Westphal Longwood Fund II, L.P. (entity)

Current Position

Ticker	Shares	Value
FLKS	2,786,944	$1.7M

Shares reported on the most recent Form 4, priced at the 2016-03-15 close.

Grade by Ticker

CFLKS

awaiting returns

Get an email the next time Longwood Fund II, L.P. files

Free account. One email when the next filing comes in.

Follow Longwood Fund II, L.P. for free

Buy Track Record

Filings1

Only 1 discretionary filing — too few to score

Discretionary filings only. 10b5-1 plan trades, tax withholding and option exercises are excluded, and each column is one row per filing rather than per execution lot.

Sell Track Record

Filings1

Only 1 decision-sell filing — too few to score

Decision sells only — a first sale after buying the stock, or a sale by a fund or 10% owner. Ordinary sales by officers and directors show no relationship to what the stock does next, so they are counted but not scored.